來凱醫藥料中期虧損收窄
來凱醫藥-B(2105)料中期虧損收窄,至不多於500萬元人民幣(下同),按年減少約96%,去年同期虧損約為1.3億元。期內收入約為1.45億元至1.55億元,去年同期則為零。
Last Update:
17 8 月, 2026
Please share this article if you like it!
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.